The latest clinical results related to COVID-19, bronchiectasis, idiopathic pulmonary fibrosis, and asthma will be presented Monday morning. “This session is going to open the door to new treatments that could be available almost immediately or are very close,” said International Conference Committee Chair Andrew Halayko, PhD, ATSF.

The biggest networking event this week at ATS 2022, Saturday’s Research Program Benefit was designed to be more casual than past events, offering attendees more time to socialize and celebrate being together again while supporting the work of early-career scientists.

The ATS’s four-day Clinical Year in Review began Sunday with co-chairs Jose L. Gomez, MD, MS; Rupal J. Shah, MD, MSCE; and Juliana C. Ferreira, MD, PhD. The session’s panelists highlighted impactful work published in the past year in pulmonary vascular disease, interstitial lung disease, lung cancer, and pneumonia and pulmonary infections.

Rana Awdish, MD, and Megan M. Hosey, PhD, spoke of restoration in the aftermath of the COVD-19 pandemic as the Keynote Series speakers Sunday morning. They shared stories of healing from health care professionals and the people for whom they care.

Jesse Roman, MD, a founding leader of the Health Equity Subcommittee within the ATS Health Equity and Diversity Committee and current treasurer of the Society, imparted powerful messages about diversity and mentorship as he spoke of his family lineage in Puerto Rico and his journey from there to his current leadership positions at Jefferson Health…

Designed to promote healthfulness through exercise, the Wellness Challenge encourages participants to take 30,000 steps during the International Conference for a chance to win prizes. Leaderboards in the Wellness Challenge booth in the lobby of Moscone South, online, and in the app track this year’s steppers.

Terri A. Laguna, MD, MSci, will co-chair this session exploring the differences between adult and pediatric sleep patients, the status of the pediatric pulmonology workforce, the effects of COVID-19 on children, and disparities in pediatric respiratory disease.

Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, will provide a retrospective look at the lessons learned since the first case of HIV/AIDS was reported in the early 1980s in this session on the evolution of HIV care and the global impact of pulmonary complications…

The burning of fossil fuels results in hundreds of thousands of premature deaths and numerous respiratory illnesses annually. Mary Berlik Rice, MD, MPH, and John Kerry, U.S. Special Presidential Envoy for Climate, will address how medical professionals, governments, and private businesses can confront this crisis.

The second of four Clinical Year in Review sessions will highlight chronic obstructive pulmonary disease and asthma. “It is focused on the most important, most relevant advances in diagnostics and therapeutics in lung disease,” said session co-chair Jose L. Gomez, MD, MS.